Literature DB >> 12103433

Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR).

Istvan Arany1, Kenneth G Grattendick, Stephen K Tyring.   

Abstract

The effects of various proinflammatory cytokines on the transcription of human papillomaviruses (HPVs) have been demonstrated. On the other hand, the role of anti-inflammatory cytokines has not been elaborated, despite the fact that levels of interleukin-10 (IL-10) have been found significantly elevated in cervical dysplasias or carcinomas as well as in the cervix of HIV-positive individuals. These conditions are also associated with elevated viral transcription. Thus, the impact of IL-10 on HPV transcription might be important in pathogenesis of cervical lesions in both immunocompetent or immunosuppressed individuals. In this paper we describe the effects of IL-10 on the transcription of HPV type 16. We found that treatment of HPV 16-positive cervical carcinoma cells with IL-10 increased mRNA levels of the E7 early gene at the level of transcription. Similarly, IL-10 significantly and dose-dependently induced the transcription from the HPV early promoter in a reporter system. Employing deletion mutants we determined that this induction is mapped to the 5' segment of the URR. Transient transfection of an antisense-STAT3-expression vector abolished IL-10-induced reporter activity as well as HPV 16 E7 expression. This suggests that STAT3 either directly binds to the URR and stimulates transcription or affects expression and/or binding of transcription factors that bind to the 5'-region. Our findings suggest a mechanism by which--in addition to its immunosuppressive effects--IL-10 might enhance persistence and progression of HPV-related lesions under conditions (e.g. dysplastic progression, HIV infection) when the cytokine expression in the cervical microenvironment changes. Copyright 2002 Elsevier Science BV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103433     DOI: 10.1016/s0166-3542(02)00070-0

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  17 in total

1.  Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Denise A Galloway; Janet R Daling; Mari Malkki; Effie W Petersdorf; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 2.  Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Authors:  Kirvis Torres-Poveda; Margarita Bahena-Román; Claudia Madrid-González; Ana I Burguete-García; Víctor Hugo Bermúdez-Morales; Oscar Peralta-Zaragoza; Vicente Madrid-Marina
Journal:  World J Clin Oncol       Date:  2014-10-10

3.  CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.

Authors:  Cinthya E Díaz-Benítez; Karla R Navarro-Fuentes; Jacqueline A Flores-Sosa; Janet Juárez-Díaz; Felipe J Uribe-Salas; Edgar Román-Basaure; Ludwig E González-Mena; Patricia Alonso de Ruíz; Guillermina López-Estrada; Alfredo Lagunas-Martínez; Victor H Bermúdez-Morales; Juan M Alcocer-González; Jesús Martínez-Barnetche; Rogelio Hernández-Pando; Yvonne Rosenstein; José Moreno; Vicente Madrid-Marina
Journal:  J Clin Immunol       Date:  2009-03-04       Impact factor: 8.317

4.  Evaluation of mRNA expression levels of IL-17A and IL-10 cytokines in cervical cancer.

Authors:  Setareh Akhavan; Aghdas Safari; Sima Azizmohammadi; Susan Azizmohammadi; Maysam Aslami; Emad Yahaghi; Mehri Seifoleslami
Journal:  Tumour Biol       Date:  2016-01-29

Review 5.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.

Authors:  Shirish Shukla; Gauri Shishodia; Sutapa Mahata; Suresh Hedau; Arvind Pandey; Suresh Bhambhani; Swaraj Batra; Seemi F Basir; Bhudev C Das; Alok C Bharti
Journal:  Mol Cancer       Date:  2010-10-27       Impact factor: 27.401

7.  Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.

Authors:  Gaurav Verma; Kanchan Vishnoi; Abhishek Tyagi; Mohit Jadli; Tejveer Singh; Ankit Goel; Ankita Sharma; Kiran Agarwal; Subhash Chandra Prasad; Durgatosh Pandey; Shashi Sharma; Ravi Mehrotra; Sukh Mahendra Singh; Alok Chandra Bharti
Journal:  Cancer Med       Date:  2017-02-03       Impact factor: 4.452

8.  Smoking enhances risk for new external genital warts in men.

Authors:  Dorothy J Wiley; David Elashoff; Emmanuel V Masongsong; Diane M Harper; Karen H Gylys; Michael J Silverberg; Robert L Cook; Lisette M Johnson-Hill
Journal:  Int J Environ Res Public Health       Date:  2009-03-20       Impact factor: 3.390

9.  Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis.

Authors:  Shirish Shukla; Sutapa Mahata; Gauri Shishodia; Arvind Pandey; Abhishek Tyagi; Kanchan Vishnoi; Seemi F Basir; Bhudev C Das; Alok C Bharti
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.

Authors:  K Torres-Poveda; A I Burguete-García; M Bahena-Román; R Méndez-Martínez; M A Zurita-Díaz; G López-Estrada; K Delgado-Romero; O Peralta-Zaragoza; V H Bermúdez-Morales; D Cantú; A García-Carrancá; V Madrid-Marina
Journal:  BMC Cancer       Date:  2016-05-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.